FOIA FDA's Internal Foreign Inspection Gap Analysis for Dual Monetization
- Organization
- Food and Drug Administration (FDA)
- Sector
- FDA Foreign Inspection Workgroup & U.S. Food Importers
- Location
- United States
Source reference
Executive summary
Current state
FDA faces a critical capacity gap where 432 investigators at 90% capacity cannot meet FSMA mandates for 19,200+ annual foreign inspections plus domestic cycles, while simultaneously failing to implement a performance management system recommended by GAO since 2015 with a July 2026 deadline approaching.
Market catalyst
FDA's internal workgroup analyzing foreign inspection workload has produced detailed findings about capacity gaps but hasn't published them publicly - creating an intelligence vacuum where both FDA (seeking solutions) and importers (assessing risk) need the same analysis but can't access it.
This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.
Field notes
Intelligence ledger
Add new evidence, corrections, or practical context to this directive. Keep claims attributable to a source where possible.
Sign in to add intelligence or vote on a field note.
Field intel logs: [ 0 ] entries. No operative updates submitted for this directive. Submit intel to claim clearance.